Exhibit 8
Joint Filing Agreement
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he, she or it knows that such information is inaccurate.
Date: June 21, 2024
| Novartis BidCo Germany AG | |||
| By: | /s/ Jan-Hendrik Petersen | ||
| Name: | Jan-Hendrik Petersen | ||
| Title: | As Authorized Signatory | ||
| Novartis BidCo AG | |||||
| By: | /s/ Daniel Weiss | /s/ Bertrand Bugnon | |||
| Name: | Daniel Weiss | Name: | Bertrand Bugnon | ||
| Title: | As Authorized Signatory | Title: | As Authorized Signatory | ||
| Novartis Pharma AG | |||||
| By: | /s/ Lukas Foertsch | /s/ Luca Hammel | |||
| Name: | Lukas Foertsch | Name: | Luca Hammel | ||
| Title: | As Authorized Signatory | Title: | As Authorized Signatory | ||
| Novartis AG | |||||
| By: | /s/ David Quartner | /s/ Tariq ElRafie | |||
| Name: | David Quartner | Name: | Tariq ElRafie | ||
| Title: | As Attorney | Title: | As Attorney | ||
